3164.0 HPV Vaccination in Communities At Risk

Monday, November 9, 2009: 10:30 AM
Oral
HPV vaccine could improve womenís health by sharply reducing cervical cancer rates, but achieving this requires broad uptake of the vaccine, especially among those at highest risk. In this session, we will present findings from the Carolina HPV Immunization Measurement and Evaluation (CHIME) Project, a multi-component evaluation of HPV vaccine use in areas with high cervical cancer rates. We start with micro-level issues related to measurement and finish with macro-level issues related to policy. Topics include proper measurement of the factors likely to affect HPV vaccine uptake, findings from the nationís first longitudinal study of HPV vaccine uptake, groundbreaking data on HPV vaccine-related pain, and parentsí support for school-based requirements for HPV vaccination. The session is intended to be useful to behavioral scientists, practitioners, and policy makers.
Session Objectives: 1. Measure key parental beliefs about HPV vaccine; 2. Identify factors that influence HPV vaccine initiation that would be useful for developing interventions; 3. Describe whether pain associated with HPV vaccination is greater or less than pain from other adolescent vaccines; and 4. Describe parental support for school-based HPV vaccination requirements.
Moderator:

10:30 AM
Development of the Carolina HPV Immunization Attitudes Scale (CHIAS)
Annie-Laurie McRee, MPH, Noel T. Brewer, PhD, Paul L. Reiter, PhD, Sami L. Gottlieb, MD, MSPH and Jennifer S. Smith, PhD
10:50 AM
Longitudinal predictors of HPV vaccine uptake
Noel T. Brewer, PhD, Sami L. Gottlieb, MD, MSPH, Paul L. Reiter, PhD, Annie-Laurie McRee, MPH, Nicole Liddon, PhD, Lauri E. Markowitz, MD and Jennifer S. Smith, PhD
11:10 AM
How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose vaccine regimen
Paul L. Reiter, PhD, Noel T. Brewer, PhD, Sami L. Gottlieb, MD, MSPH, Annie-Laurie McRee, MPH and Jennifer S. Smith, PhD
11:30 AM
Acceptability of school requirements for human papillomavirus vaccine
Jennifer S. Smith, PhD, Noel T. Brewer, PhD, Yuli Chang, BA, Sarah Guerry, MD, Erica M. Pettigrew, Nicole Liddon, PhD, Lauri E. Markowitz, MD and Sami L. Gottlieb, MD, MSPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Women's Caucus
Endorsed by: APHA-Committee on Women's Rights, Epidemiology, HIV/AIDS, Latino Caucus, Maternal and Child Health, Public Health Nursing, Socialist Caucus, Social Work

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Women's Caucus